TABLE 2

Clinical characteristics of children enrolled in AREST CF for which computed tomography scans were available

1–2 years3–4 years5–6 years
Age years1.66±0.203.68±0.215.66±0.21
Males70/139 (50.36)81/162 (50.00)82/167 (49.10)
Test centre Perth/Melbourne72/139 (51.80)79/162 (48.77)67/167 (40.12)
Genotype
 Homozygous Phe508del/Phe508del71/139 (51.08)85/158 (53.80)83/161 (51.55)
 Heterozygous Phe508del/other64/139 (46.04)68/158 (43.04)71/161 (44.10)
Meconium ileus27/134 (20.15)30/156 (19.23)31/158 (19.62)
Pancreatic sufficient20/139 (14.39)25/162 (15.43)25/164 (15.24)
PSA culture positive14/139 (10.07)20/162 (12.35)22/167 (13.17)
Structural lung disease
 Bronchiectasis presence46/139 (33.09)98/162 (60.49)123/167 (73.65)
 Trapped air presence106/139 (76.26)99/162 (61.11)127/167 (76.05)
 Mucus plugging presence11/139 (7.91)44/162 (27.16)62/167 (37.13)
 Bronchial wall thickening presence106/139 (76.26)142/162 (87.65)154/167 (92.22)
Spirometry measured lung function at age 5–6 years
 FEV1 Z-score−0.06±1.19−0.08±1.24−0.10±1.24
 FVC Z-score0.57±1.180.57±1.220.65±1.19
 FEV1/FVC Z-score−0.70±0.98−0.70±1.01−0.75±0.99
 FEF25–75 Z-score−0.35±1.17−0.33±1.18−0.34±1.18

Data are presented as n/N (%) or mean±sd. Scans were divided into age groups, with only a single scan per child in each age group. There are multiple scans of the same child in different age groups. PSA: Pseudomonas aeruginosa; FEV1: forced expiratory volume in 1s; FVC: forced vital capacity: FEF25–75: forced expiratory flow at 25–75% of FVC.